奥扎格雷钠联合超声波治疗急性脑梗死临床观察  

Clinical observation of combined use sodium ozagrel and ultrasonic therapy for acute cerebral infarction

作　　者：陈小江[1] 梁学标[1] 李燕珍[1] 阳小云[1] 

机构地区：[1]广东医学院附属医院神经内科,广东省湛江524001

出　　处：《中国基层医药》2009年第9期1569-1570,共2页Chinese Journal of Primary Medicine and Pharmacy

摘　　要：目的观察奥扎格雷钠联合超声波治疗急性脑梗死的临床疗效。方法83例急性脑梗死患者随机分为两组（治疗组42例、对照组41例），两组均在常规基础治疗上给予奥扎格雷钠静脉滴注，治疗组则另加用经脑超声波治疗，观察两组治疗前后神经功能缺损评分、临床疗效等情况。结果治疗后两组患者神经功能缺损及临床疗效评定比较差异均有统计学意义（P〈0．05）。结论奥扎格雷钠联合超声波治疗急性脑梗死有利于促进患者神经功能恢复，从而提高临床疗效。Objective To observe the clinical effect of Ozagrel sodium with ultrasonic therapy in patients with acute cerebral infarction （ACI）. Methods Eighty-three ACI patients were randomly divided into 2 groups ：ultrasonic therapy group（ n =42） received Ozagrel sodium and ultrasonic therapy,whereas control group（ n =41 ） only accepted the Ozagrel sodium for injection. Both two groups were under conventional treatment. The level of laboratory index and the neurological impairment were detected before and after treatment. And the clinical effect were detected in the end of the treatment. Results The neurological impairment and the clinical effect defected after therapy in both groups, had statistical difference（ P 〈 0. 05 ）, especially in the ultrasonic therapy group. Conclusion Ozagrel sodium with ultrasonic therapy in patients with ACI could promote recovery of the neurological function, thus increase clinical effect.

关 键 词：脑梗塞 超声疗法 奥扎格雷钠 

分 类 号：R74[医药卫生—神经病学与精神病学]